NTRA

NASDAQ · Biotechnology

Natera Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$390.79

-0.11 (-0.03%)

As of Sep 23, 9:39 PM ET ·

Day Range $384.96 — $394.86

52W Range $157.43 — $366.70

Performance

1D —

1W —

1M —

3M —

6M —

1Y +138.42%

YTD +70.77%

Open$386.94

Previous Close$390.90

Day High$394.86

Day Low$384.96

52W High$366.70

52W Low$157.43

Volume—

Avg Volume1.21M

Market Cap52.80B

P/E Ratio—

EPS$-1.37

SectorBiotechnology

Technical Indicators

Full analysis →

SMA 50 $229.31 Above

SMA 200 $186.42 Above

RSI (14) 38.6 Neutral

Trend Golden Cross Bullish

Analyst Ratings

Strong Buy

30 analysts

26 Buy 4 Hold 0 Sell

Price Target -63.4% upside

Current
$390.79

Target
$142.91

$88.14 $142.91 avg $188.78

Key Financials

	FY 2026	FY 2025	FY 2024
Revenue	2.41B	1.71B	5.13B
Net Income	-217,629,626	-138,774,736	875.75M
Profit Margin	-9.0%	-8.6%	17.1%
EBITDA	-322,220,494	-216,883,569	1.33B
Free Cash Flow	—	—	778.23M
Rev Growth	+41.1%	+41.1%	+14.5%
Debt/Equity	0.05	0.05	1.21

Biotechnology Peers

Symbol	Name	Price	Change	P/E	Mkt Cap
ABBV	Abbvie Inc	$265.08	-0.05%	74.0	466.74B
AMGN	Amgen Inc	$406.09	-1.01%	23.7	207.25B
GILD	Gilead Sciences Inc	$151.37	-0.85%	—	187.10B
VRTX	Vertex Pharmaceuticals Inc	$516.34	+0.26%	29.7	130.64B
REGN	Regeneron Pharmaceuticals	$801.82	-0.26%	18.6	80.58B
ALNY	Alnylam Pharmaceuticals Inc	$246.51	-2.04%	40.0	32.33B